Restless legs syndrome/Willis-Ekbom disease in type 2 diabetes as the initial manifestation of Parkinson's disease and major cardiovascular disease.
Department of Family Medicine, Cardinal Tien Hospital, School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.|Department of Geriatric Medicine, Cardinal Tien Hospital, School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
Chun-Hsien
CH
Hsu
Department of Family Medicine, Cardinal Tien Hospital, School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
Shu-Man
SM
Yu
Department of Family Medicine, Cardinal Tien Hospital, School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.|Department of Geriatric Medicine, Cardinal Tien Hospital, School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
Shu Chuen
SC
Lau
Department of Pathology, Cardinal Tien Hospital, School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
Yen-Lin
YL
Chen
Department of Internal Medicine, Cardinal Tien Hospital, School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
Dee
D
Pei
Department of Psychiatry, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.|Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
I-Chao
IC
Liu
D000368:Aged; D000588:Amines / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000627:therapeutic use; D016893:Carotid Stenosis / Q000175:diagnosis* / Q000188:drug therapy; D002998:Clonazepam / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000175:diagnosis* / Q000188:drug therapy; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000175:diagnosis; D000077206:Gabapentin; D006801:Humans; D006973:Hypertension / Q000175:diagnosis* / Q000188:drug therapy; D000077405:Irbesartan; D008297:Male; D010300:Parkinson Disease / Q000175:diagnosis* / Q000188:drug therapy; D011788:Quality of Life; D012148:Restless Legs Syndrome / Q000175:diagnosis* / Q000188:drug therapy; D012890:Sleep / Q000502:physiology; D013777:Tetrazoles / Q000627:therapeutic use; D016896:Treatment Outcome; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use
D000588:Amines; D000700:Analgesics; D000927:Anticonvulsants; D000959:Antihypertensive Agents; D000978:Antiparkinson Agents; D001713:Biphenyl Compounds; D003509:Cyclohexanecarboxylic Acids; D013777:Tetrazoles; D005680:gamma-Aminobutyric Acid; D002998:Clonazepam; D000077206:Gabapentin; D000077405:Irbesartan; D001241:Aspirin
Parkinson's disease; cardiovascular disease; restless legs syndrome/Willis-Ekbom disease; type 2 diabetes